- 9 May 2017 Sonia Quaratino appointed Kymab CMO
- 23 Jan 2017 Arndt Schottelius appointed Executive VP R&D
- 9 Jan 2017 Kymab expands Infectious Disease Programmes
- 5 Dec 2016 Antibody shows dramatic post-transplant benefit
- 24 Nov 2016 Kymab secures US$100 million Series C funding
- 8 Sep 2016 Kymab's early steps towards HIV vaccine
- 21 Apr 2016 New therapeutic heads: Cambridge TV interview
- 18 Apr 2016 Kymab and Heptares seek cancer therapeutics
- 15 Apr 2016 Kymab features on BBC News
- 14 Apr 2016 Three appointments to lead key therapeutic areas